Some studies have also showed that ANGPTL4 loss-of-function mutations are associated with substantially lower TG levels, and a lower risk of coronary artery disease (CAD) and type 2 diabetes (T2D) [22–25]. The gene discussed is ANGPTL4; the disease is type 2 diabetes mellitus.